Ozempic® is FDA-approved as therapy to use alongside diet and exercise to control blood sugar in adults with type 2 diabetes. Ozempic® can also help reduce the risk of major cardiovascular events, such as heart attacks and stroke, in adults with type 2 diabetes and cardiovascular disease. Ozempic® is not recommended for adults with type 1 diabetes.
We are committed to offering personalized solutions for our patients. While Ozempic® (semaglutide) is an excellent choice for many, we want to highlight alternative options to ensure patients can access the most suitable treatment. Based on availability and individual needs, our skilled online doctors may offer or prescribe another GLP-1 to treat type 2 diabetes. These GLP-1 options include:
- Compounded Semaglutide: In the event of a national shortage in which Ozempic® is commercially unavailable according to the FDA shortages list, physicians may prescribe compounded semaglutide. prescribed Although compounded semaglutide is not FDA-approved, our preferred pharmacy provider complies with pertinent federal and state laws and FDA regulations.*
- Rybelsus® (semaglutide): This oral GLP-1 medication provides a convenient option for those who prefer a pill over an injection.
- Mounjaro® (tirzepatide): This dual-action GLP-1 and GIP receptor agonist helps regulate blood sugar levels and may be recommended for patients looking for a comprehensive approach to managing their diabetes.
- Trulicity® (dulaglutide): Trulicity® is a once-weekly injection known for its user-friendly design, featuring a pre-filled, disposable pen.
- Victoza® ((liraglutide):Victoza® is a daily injectable GLP-1 drug with a proven track record in managing diabetes.
- Bydureon® (exenatide): Bydureon® is unique for its extended-release formulation, requiring only once-weekly injections.
*As of 8/15/2024, availability for compounded semaglutide is currently limited to residents in the following states: AZ, CA, CO, DE, FL, GA, HI, IA, ID, IL KS, MA, MD, ME, MO, MT, ND, NE, NH, NM, NV, NY, OH, OK, OR, PA, RI, SD, TN, TX, UT, WA, Washington D.C. WY. Although compounded semaglutide is not FDA-approved, our pharmacy provider complies with all federal and state laws and FDA regulations. Doses of Ozempic® that are in shortage will be available as compounded semaglutide only until the shortage has ended.